Abiopharma

News list

Dudek James 🟡 adjusted position in 5.7K shares (1 derivative) of ACCO BRANDS Corp (ACCO) at $3.32 Transaction Date: Mar 14, 2026 | Filing ID: 000033

Full text

News bot March 17, 2026, 7:03 p.m.
🔍 Dudek James (Executive)

Company: ACCO BRANDS Corp (ACCO)

Report Date: 2026-03-14
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 19,700
- Total shares sold: 25,433
Detailed Transactions and Holdings:
- Acquired 19,700 shares of Common Stock (Direct)
  Date: 2026-03-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 72,540.00 | transaction_form_type: 4
- Sold 5,733 shares of Common Stock at $3.32 per share (Direct)
  Date: 2026-03-14 | Code: F | equity_swap_involved: 0 | shares_owned_after: 66,807.00 | transaction_form_type: 4
- Sold 19,700 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-14 | Code: M | Expires: 2026-03-14 | Exercise: 2026-03-14 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1
Footnotes:
- F1: Restricted Stock Units (RSUs) granted under the Issuer's Incentive Plan. Each RSU represents the right to receive one share of the Issuer's common stock on March 14, 2026, provided the Reporting Person remains employed by the Issuer at that time, subject to acceleration as provided in said Plan.